Aurobindo Pharma Share Price


'Aurobindo Pharma Share Price' - 4 News Result(s)

  • Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US

    Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US

    Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.

  • Aurobindo Pharma Shares Extend Gains To Second Day After US Deal

    Aurobindo Pharma Shares Extend Gains To Second Day After US Deal

    Analysts said the deal was positive for Aurobindo Pharma, which said it would make the company the second largest generic player in the US by number of prescriptions. Aurobindo Pharma shares closed 9 per cent higher on Thursday. On Friday, the shares were set to close higher for a third session in a row. At the day's highest level, the shares have ...

  • Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition

    Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition

    Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...

  • Aurobindo Pharma Surges Over 4%, Hits 52-Week High

    Aurobindo Pharma Surges Over 4%, Hits 52-Week High

    Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling seizures.

'Aurobindo Pharma Share Price' - 4 News Result(s)

  • Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US

    Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US

    Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.

  • Aurobindo Pharma Shares Extend Gains To Second Day After US Deal

    Aurobindo Pharma Shares Extend Gains To Second Day After US Deal

    Analysts said the deal was positive for Aurobindo Pharma, which said it would make the company the second largest generic player in the US by number of prescriptions. Aurobindo Pharma shares closed 9 per cent higher on Thursday. On Friday, the shares were set to close higher for a third session in a row. At the day's highest level, the shares have ...

  • Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition

    Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition

    Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...

  • Aurobindo Pharma Surges Over 4%, Hits 52-Week High

    Aurobindo Pharma Surges Over 4%, Hits 52-Week High

    Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling seizures.

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................